Largest Biotechnology companies in Germany by Market Capitalization

This ranking features the largest 17 Biotechnology companies in Germany ranked by Market Capitalization, totaling a Market Capitalization of USD 185.82 B, for July 10, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Germany has the highest Market Capitalization ?

The Biotechnology company in Germany with the highest Market Capitalization is Siemens Healthineers AG (XETRA: SHL.DE) at USD 62.30 B.

Which Biotechnology company in Germany has the lowest Market Capitalization ?

The Biotechnology company in Germany with the lowest Market Capitalization is Mainz Biomed B.V. (NasdaqCM: MYNZ) at USD 7.06 M.

What are the top 10 Biotechnology companies in Germany by Market Capitalization ?

The top 10 Biotechnology companies in Germany by Market Capitalization are Siemens Healthineers AG, MERCK Kommanditgesellschaft auf Aktien, Bayer AG, BioNTech SE, Anbio Biotechnology Class A Ordinary Shares, Eckert & Ziegler Strahlen- und Medizintechnik AG, Evotec SE, CureVac N.V., Immatics N.V. and Formycon AG.

What are the bottom 10 Biotechnology companies in Germany by Market Capitalization ?

The bottom 10 Biotechnology companies in Germany by Market Capitalization are Mainz Biomed B.V., Vivoryon Therapeutics N.V., BRAIN Biotech AG, Vita 34 AG, Heidelberg Pharma AG, Stratec SE, Atai Life Sciences N.V., Formycon AG, Immatics N.V. and CureVac N.V..